|
Rep. Jehan Gordon-Booth
Filed: 5/6/2024
| | 10300HB0443ham001 | | LRB103 04013 CES 72218 a |
|
|
1 | | AMENDMENT TO HOUSE BILL 443
|
2 | | AMENDMENT NO. ______. Amend House Bill 443 by replacing |
3 | | everything after the enacting clause with the following: |
4 | | "Section 1. Short title. This Act may be cited as the |
5 | | Deveraux Hubbard II Blood Clot Prevention and Treatment Act. |
6 | | Section 5. Prevention of morbidity and mortality as a |
7 | | result of deep venous thromboembolism. |
8 | | (a) The Department of Public Health shall carry out |
9 | | projects to increase education, awareness, and diagnosis of |
10 | | deep venous thrombosis or pulmonary embolism and to reduce the |
11 | | incidence of morbidity and mortality caused by blood clots. |
12 | | The projects may be carried out by the Department directly or |
13 | | through awards of grants or contracts to public or nonprofit |
14 | | private entities. The Department may directly, or through |
15 | | awards or grants, provide technical assistance with respect to |
16 | | the planning, development, and operation of the projects. |
|
| | 10300HB0443ham001 | - 2 - | LRB103 04013 CES 72218 a |
|
|
1 | | (b) A project under this Section may include: |
2 | | (1) the implementation of public information and |
3 | | education programs for: |
4 | | (A) the prevention of death from deep venous |
5 | | thrombosis or pulmonary embolism; |
6 | | (B) broadening the awards of the public |
7 | | concerning: |
8 | | (i) the risk factors for and the symptoms of |
9 | | deep venous thrombosis or pulmonary embolism; |
10 | | (ii) target populations with greater risk for |
11 | | deep venous thrombosis or pulmonary embolism, |
12 | | including women, seniors, cancer patients, |
13 | | hospitalized patients, pregnant and postpartum |
14 | | women, Black Americans, and those in rural areas; |
15 | | and |
16 | | (iv) the public health consequences of deep |
17 | | venous thrombosis or pulmonary embolism; and |
18 | | (C) increasing screening, detection, and diagnosis |
19 | | of deep venous thrombosis or pulmonary embolism; and |
20 | | (2) surveillance of the prevalence and incidence of |
21 | | deep venous thrombosis or pulmonary embolism to improve |
22 | | patient outcomes. |
23 | | (c) The Department may, in awarding grants or entering |
24 | | into contracts under this Section, give priority to entities |
25 | | seeking to carry out projects that target the populations |
26 | | referred to in item (ii) of subparagraph (B) of paragraph (1) |
|
| | 10300HB0443ham001 | - 3 - | LRB103 04013 CES 72218 a |
|
|
1 | | of subsection (b). |
2 | | (d) The Department shall ensure that projects carried out |
3 | | under this Section are coordinated, as appropriate, with other |
4 | | agencies that carry out activities regarding deep venous |
5 | | thrombosis or pulmonary embolism. |
6 | | (e) The Department shall: |
7 | | (1) collect and analyze the findings of research |
8 | | conducted with respect to deep venous thrombosis or |
9 | | pulmonary embolism; and |
10 | | (2) taking into account such findings, publish on the |
11 | | Department's website the best practices for physicians and |
12 | | other health care providers who provide care to |
13 | | individuals with deep venous thrombosis or pulmonary |
14 | | embolism. |
15 | | Section 10. Advisory Committee for Deep Venous Thrombosis |
16 | | or Pulmonary Embolism Prevention. |
17 | | (a) Not later than 180 days after the effective date of |
18 | | this Act, the Director of Public Health shall establish an |
19 | | advisory committee to be known as the Advisory Committee for |
20 | | Deep Venous Thrombosis or Pulmonary Embolism Prevention. |
21 | | (b) The Advisory Committee shall: |
22 | | (1) identify the aggregate number of individuals in |
23 | | the State who experience deep venous thrombosis or |
24 | | pulmonary embolism annually; |
25 | | (2) identify how data are collected regarding deep |
|
| | 10300HB0443ham001 | - 4 - | LRB103 04013 CES 72218 a |
|
|
1 | | venous thrombosis or pulmonary embolism and the adverse |
2 | | outcomes associated with such conditions; |
3 | | (3) identify how deep venous thrombosis or pulmonary |
4 | | embolism impacts the lives of individuals in the State; |
5 | | (4) identify the standard of care for deep venous |
6 | | thrombosis or pulmonary embolism surveillance, detection, |
7 | | and treatment; |
8 | | (5) identify emerging treatments, therapies, and |
9 | | research relating to deep venous thrombosis or pulmonary |
10 | | embolism; |
11 | | (6) develop recommendations to help health care |
12 | | providers identify patients who may be at a higher risk of |
13 | | forming deep venous thrombosis or pulmonary embolism in |
14 | | health care facilities; |
15 | | (7) develop recommendations to help improve patient |
16 | | awareness of deep venous thrombosis or pulmonary embolism; |
17 | | (8) develop recommendations with respect to the |
18 | | standard of care for patients at risk of forming deep |
19 | | venous thrombosis or pulmonary embolism; |
20 | | (9) develop recommendations relating to providing |
21 | | patients and their families with written notice of |
22 | | increased risks of forming deep venous thrombosis or |
23 | | pulmonary embolism; and |
24 | | (10) identify the estimated level of State funding |
25 | | needed for deep venous thrombosis or pulmonary embolism |
26 | | services to meet the needs of high-risk populations. |
|
| | 10300HB0443ham001 | - 5 - | LRB103 04013 CES 72218 a |
|
|
1 | | (c) The Advisory Committee shall be composed of members |
2 | | appointed by the Director as follows: |
3 | | (1) at least one individual who has experienced blood |
4 | | clots; |
5 | | (2) at least one family member of an individual who |
6 | | died from deep venous thrombosis or pulmonary embolism; |
7 | | (3) at least one health services researcher; |
8 | | (4) at least one health care provider; |
9 | | (5) at least one representative of a health plan; |
10 | | (6) at least one representative of a hospital or |
11 | | health system; |
12 | | (7) at least one epidemiologist; |
13 | | (8) at least one public health expert; |
14 | | (9) at least one patient representative or |
15 | | representative of a patient group; |
16 | | (10) at least one physician licensed to practice |
17 | | medicine in all its branches and who represents a |
18 | | statewide organization of physicians; and |
19 | | (11) such individuals representing other interested |
20 | | parties or associations, as the Director determines |
21 | | appropriate. |
22 | | (d) Not later than 18 months after the first meeting of the |
23 | | Advisory Committee, the Director shall submit to the General |
24 | | Assembly, and make publicly available, a report: |
25 | | (1) summarizing the meetings and findings of the |
26 | | Advisory Committee; and |
|
| | 10300HB0443ham001 | - 6 - | LRB103 04013 CES 72218 a |
|
|
1 | | (2) describing the recommendations of the Advisory |
2 | | Committee for legislative and administrative action to |
3 | | improve deep venous thrombosis or pulmonary embolism |
4 | | prevention, treatment, and diagnosis, including the |
5 | | recommendations described in paragraphs (6) through (9) of |
6 | | subsection (b). |
7 | | (e) The Advisory Committee shall terminate on the earlier |
8 | | of: |
9 | | (1) the date on which the Director submits the report |
10 | | under subsection (d); or |
11 | | (2) the date that is 18 months after the first meeting |
12 | | of the Advisory Committee. |
13 | | Section 15. Deep venous thrombosis or pulmonary embolism |
14 | | surveillance study and report. |
15 | | (a) The Department of Public Health shall conduct or |
16 | | support a study on model systems of deep venous thrombosis or |
17 | | pulmonary embolism surveillance, including the use of |
18 | | electronic medical record-based methods of detecting deep |
19 | | venous thrombosis and pulmonary embolism, International |
20 | | Classification of Diseases codes, or other population-based |
21 | | surveillance. |
22 | | (b) Not later than one year after the effective date of |
23 | | this Act, the Department shall submit to the General Assembly |
24 | | and the Advisory Committee for Deep Venous Thrombosis or |
25 | | Pulmonary Embolism a report detailing the results of the study |